You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

XELOX

Showing 1 - 25 of 359
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer, MSS Trial in Beijing (Cadonilimab, Oxaliplatin, Capecitabine)

Recruiting
  • Rectal Cancer
  • MSS
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Apr 13, 2023

Gastric Cancer Trial in China (Experimental dose: modified XELOX + sintilimab, Standard dose: standard XELOX + sintilimab)

Recruiting
  • Gastric Cancer
  • Experimental dose: modified XELOX + sintilimab
  • Standard dose: standard XELOX + sintilimab
  • Guangzhou, Guangdong, China
  • +9 more
Jun 23, 2023

Gastric Cancer Trial in Xi'an (Carrelizumab combined with XELOX)

Recruiting
  • Gastric Cancer
  • Carrelizumab combined with XELOX
  • Xi'an, Shanxi, China
    Wang Nan
Feb 6, 2023

Gastric Cancer Trial (Fruquintinib)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Oct 17, 2023

Gastrointestinal Neuroendocrine Carcinoma Trial in Beijing (Durvalumab and Chemotherapy(oxaliplatin and capecitabine))

Recruiting
  • Gastrointestinal Neuroendocrine Carcinoma
  • Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 1, 2023

Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

Not yet recruiting
  • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
  • XELOX combined with Fruquintinib and Sintilimab
  • (no location specified)
Oct 17, 2023

Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Recruiting
  • Tislelizumab
  • +7 more
  • Beijing, China
    Lin Yang
Jul 21, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

Carcinoma, Gastrointestinal Diseases, Stomach Cancer Trial (Anlotinib HCl capsule, Penpulimab Injection, XELOX)

Not yet recruiting
  • Carcinoma
  • +6 more
  • Anlotinib hydrochloride capsule
  • +2 more
  • (no location specified)
Aug 8, 2022

HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Locally Advanced Resectable Gastric Cancer
  • (no location specified)
Sep 3, 2023

Colorectal Carcinoma Trial in Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)

Recruiting
  • Colorectal Carcinoma
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Mar 23, 2023

Metastatic Colorectal Cancer Trial in China (HLX10/Placebo, HLX04/Avastin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Dec 19, 2022

Gastric Cancer Trial in Shanghai (PLD, Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Shanghai, China
    Shanghai General Hospital
Sep 7, 2022

A Small-sample, Real-world Study of Sintilimab Plus

Recruiting
  • Colorectal Cancer
  • Sintilimab ，bevcizumab/cetuximab，XELOX
  • Xi'an, Shanxi, China
    Yang Jianjun
Sep 14, 2022

Cancer of Stomach, Adenocarcinoma Trial in Hong Kong (5-FU, Leucovorin, Oxaliplatin, Docetaxel, XELOX)

Recruiting
  • Cancer of Stomach, Adenocarcinoma
  • 5-FU, Leucovorin, Oxaliplatin, Docetaxel
  • XELOX
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Mar 21, 2022

Advanced Rectal Cancer Trial in Guangzhou (XELOX, Capecitabine monotherapy, Radiation)

Not yet recruiting
  • Advanced Rectal Cancer
  • XELOX
  • +2 more
  • Guangzhou, Guangdong, China
    Zhenhai Lu
Oct 25, 2022

Colon Cancer Trial (Envafolimab)

Not yet recruiting
  • Colon Cancer
  • (no location specified)
Apr 13, 2022

Locally Advanced Gastric Adenocarcinoma Trial in Xi'an (Tislelizumab combined with Oxaliplatin and Capecitabine)

Active, not recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • Tislelizumab combined with Oxaliplatin and Capecitabine
  • Xi'an, Shaanxi, China
    Xijing Hospital of Digestive Diseases
Aug 17, 2022

Locally Advanced Gastric Cancer Trial in Guangzhou (Camrelizumab + SOX (oxaliplatin + Teggio) /XELOX (oxaliplatin + capecitabine

Recruiting
  • Locally Advanced Gastric Cancer
  • Camrelizumab + SOX (oxaliplatin + Teggio) /XELOX (oxaliplatin + capecitabine )
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
Sep 20, 2022

Gastric Cancer Trial in Gyeonggi-do (Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Gyeonggi-do, Korea, Republic of
    Hallym University Medical Center
Feb 4, 2022

Gastric Cancer Trial in China, Korea, Republic of, United States (IDX-1197+XELOX, IDX-1197+Irinotecan)

Recruiting
  • Gastric Cancer
  • Los Angeles, California
  • +11 more
Aug 7, 2022

Biliary Tract Tumor Trial in Nanjing (Tislelizumab, Lenvatinib, Oxaliplatin)

Recruiting
  • Biliary Tract Tumor
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Mar 14, 2022

Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in Beijing (Q-1802 Injection,Oxaliplatin Injection,Capecitabine)

Recruiting
  • Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Q-1802 Injection,Oxaliplatin Injection,Capecitabine
  • Beijing, Beijing, China
    Beijing cancer hospical
Jul 27, 2023

Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • (no location specified)
Nov 1, 2023

Colorectal Cancer Stage IV Trial in Hangzhou (IBI308)

Recruiting
  • Colorectal Cancer Stage IV
  • Hangzhou, State..., China
    Xuefeng Fang
Dec 16, 2021